/
Fortress Biotech, Inc. ( Fortress or the Company ) is a biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holding and dividend and royalty revenue streams. Fortress works in concert with our extensive network of key opinion leaders to identify and evaluate promising products and product candidates for …
The business is unprofitable at the operating level (-111.00% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 9.7%, steady but not accelerating.
Negative free cash flow of -$66M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$66M
▲ +9.7% YoY
Net Income (TTM)
$128M
▲ +114.8% YoY
Op. Margin
-84.10%
▲ +80.4pp YoY
ROIC
-31.32%
▲ +34.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$158M
▲ +18.0% YoY
Op. Cash Flow (TTM)
$158M
▲ +18.0% YoY
Net Debt
-$202M
Net Cash Position
Cash & Equiv.
$256M
5Y CAGR: +6.8%
Continue Research